ロード中...
Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes
OBJECTIVE: Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility tha...
保存先:
| 出版年: | Mol Metab |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4481465/ https://ncbi.nlm.nih.gov/pubmed/26137439 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molmet.2015.04.002 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|